Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer
Clinical trial NCT02135445 · COMPLETED
Trial details
- NCT number
- NCT02135445
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.